EXPLORE THE SCIENCE
TL;DR: Major depressive disorder and vitiligo may share immune-inflammatory gene signatures. In PLOS One in 2026, the analysis frames MAPK14 as a preliminary candidate marker that still needs clinical and laboratory validation. Key Findings Two public disease…
Read article
TL;DR: A 2026 methodology paper in European Archives of Psychiatry and Clinical Neuroscience describes EMBER-MDD, a research-only multi-omic study designed to find treatment-resistance and esketamine-response biomarkers in about 420 adults with major depressiv…
Read article
TL;DR: A 2026 Communications Biology transcriptomic analysis identified three molecular subtypes of autism spectrum disorder, each linked to a distinct phenotypic profile and biological pathway pattern. Key Findings Three molecular subtypes emerged from transc…
Read article